Sygnature Chemical Services

News

Recent news items are listed chronologically below. To view our archive of older news items please click here

To subscribe to our RSS news feed and thereby be automatically upated with changes to this page in your feed reader of choice, please click the orange icon to the right.

Sygnature sponsors Compound Libraries 2008

25 June 2008

Sygnature is sponsoring this years Compound Library meeting in Düsseldorf, Germany, 6th-8th October 2008. CEO, Dr Simon Hirst will be presenting Sygnature's approach to Hit-to-lead chemistry under the expanded remit of the conference which now covers library design and Hit-to-lead optimization.

Sygnature begins £1m expansion of facilities

14 April 2008

Sygnature announced today that it has commenced work on a new research facility at BioCity Nottingham, UK. The £1m expansion is the start of a two phase project to create two new state-of-the-art chemistry laboratories to house medicinal chemistry teams. The facility, due to complete in August 2008 will be accompanied by further growth of the medicinal chemistry group.

RespiVert selects Sygnature for Discovery Collaboration

11 January 2008

Today Sygnature announced that RespiVert Limited has selected Sygnature Chemical Services Ltd to support two new discovery collaborations. Under the agreement Sygnature will provide medicinal chemistry resources to the programs aimed at identifying novel approaches to respiratory diseases.

Sygnature and Chroma Therapeutics success

19 October 2007

Sygnature CEO, Simon Hirst has announced the successful completion of another hit-to-lead program, this time with biotechnology company, Chroma Therapeutics Ltd.

Sygnature strengthens Medicinal Chemistry

14 September 2007

Sygnature has announced that Dr David Adams, formerly Head of Chemistry at Neuro3D, and Director of Medicinal Chemistry at Vernalis, has joined the medicinal chemistry team at Sygnature.

Prosidion Hit to Lead agreement

03 August 2006

Under the services agreement, Sygnature provides parallel chemistry and libraries to support a number of drug discovery projects at Prosidion. Sygnature chemists in the BioCity Nottingham facility in the UK will continue to work with Prosidion medicinal chemists to optimize their chemical matter.